First Time Loading...

Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793

Watchlist Manager
Luoxin Pharmaceuticals Group Stock Co Ltd Logo
Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
Watchlist
Price: 4.63 CNY 2.89% Market Closed
Updated: May 5, 2024

Luoxin Pharmaceuticals Group Stock Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Luoxin Pharmaceuticals Group Stock Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Luoxin Pharmaceuticals Group Stock Co Ltd
SZSE:002793
Revenue
¥1.6B
CAGR 3-Years
-36%
CAGR 5-Years
14%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
¥2.5B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Luoxin Pharmaceuticals Group Stock Co Ltd's Revenue?
Revenue
1.6B CNY

Based on the financial report for Sep 30, 2023, Luoxin Pharmaceuticals Group Stock Co Ltd's Revenue amounts to 1.6B CNY.

What is Luoxin Pharmaceuticals Group Stock Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
14%

Over the last year, the Revenue growth was -68%. The average annual Revenue growth rates for Luoxin Pharmaceuticals Group Stock Co Ltd have been -36% over the past three years , 14% over the past five years .